Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2005
12/01/2005US20050267067 Radical reaction inhibitors, method for inhibition of radical reactions, and use thereof
12/01/2005US20050267064 Containing unmethylated CpG dinucleotides, and an allergen; desensitization
12/01/2005US20050267057 Redirect a Th2 response to a Th1 response; treating asthma, allergies, infections, cancer immunotherapy; contain unmethylated cytosine-guanine (CpG) dinucleotides
12/01/2005US20050267042 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine
12/01/2005US20050267034 Modified exendins and exendin agonists
12/01/2005US20050267033 Multi-dose erythropoietin formulations
12/01/2005US20050267031 procytotoxic agents for use in treating cancer; antitumor agents; has at least one lysine residue, modified by a peptide linkage to an amino acid residue, via the epsilon amino group
12/01/2005US20050267016 Therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266465 Interferon-alpha polypeptides and conjugates
12/01/2005US20050266460 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
12/01/2005US20050266087 Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
12/01/2005US20050266084 Modified release dosage forms
12/01/2005US20050266083 Vehicles for delivery of biologically active substances
12/01/2005US20050266081 Antimicrobial silver hydrogels
12/01/2005US20050266079 Process for making aqueous coated beadlets
12/01/2005US20050266078 Compressed tablets comprising microcapsules with modified release
12/01/2005US20050266070 Administering composition comprising hydrocodone covalently bound to a peptide; decreasing the bioavailability by intravenous or intranasal administration
12/01/2005US20050266068 Cardiolipin molecules and methods of synthesis
12/01/2005US20050266065 Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance
12/01/2005US20050266060 Transdermal delivery system for treatment of cognitive disorders
12/01/2005US20050266035 Skin protectant spray compositions
12/01/2005US20050266033 Generation of therapeutic microfoam
12/01/2005US20050266031 Pharmaceutical suspension composition
12/01/2005US20050266020 Modular transport systems for molecular substances and production and use thereof
12/01/2005US20050266010 Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders
12/01/2005US20050265965 Modified cytokines for use in cancer therapy
12/01/2005US20050265964 Stabilizing agent such as polyhydric alcohol or salt, a buffer , a sugar and polymeric compound for minimizing degradation of multifunctional glycoprotein (leukaemia inhibitory factor), additive to maintain acidic ph and isotonicity, and carriers
12/01/2005US20050265961 Biodegradable poly(beta-amino esters) and uses thereof
12/01/2005US20050265959 Hydroxyphenyl cross-linked macromolecular network and applications thereof
12/01/2005US20050265958 Nitric oxide releasing compositions and associated methods
12/01/2005US20050265957 Polymerized formamides for use in delivery of compounds to cells
12/01/2005US20050265955 Sustained release preparations
12/01/2005US20050265937 Systems and methods for changing eye color appearance
12/01/2005US20050265932 Collagenolytic active enzyme containing compositions, and their use in the dental field
12/01/2005US20050265925 Conjugates containing a lipid or a hydrophilic polymer, linked to a ligand derived from an amine- or hydroxyl-containing compound, such as a drug or protein, are stable under conditions of storage, and are cleavable under mild thiolytic conditions to regenerate the ligand
12/01/2005CA2567532A1 Methods for making injectable polymer hydrogels
12/01/2005CA2566746A1 Beta adrenergic drug conjugated to bone targeting moiety for modulating bone mass
12/01/2005CA2566713A1 Wound healing polymer compositions and methods for use thereof
12/01/2005CA2566363A1 High affinity ny-eso t cell receptor
12/01/2005CA2566247A1 Interferon-alpha polypeptides and conjugates
12/01/2005CA2566075A1 Microspheres comprising protein and showing injectability at high concentrations of said agent
12/01/2005CA2566032A1 Apparatus and method for transdermal delivery of parathyroid hormone agents
12/01/2005CA2565019A1 1,4 o-linked saccharose derivatives for stabilizing antibodies or antibody derivatives
12/01/2005CA2564332A1 Powders containing novel oligosaccharide mixtures and methods for producing the same
12/01/2005CA2563735A1 Antibodies and molecules derived therefrom that bind to steap-1 proteins
12/01/2005CA2562701A1 Cross-linked antibodies
12/01/2005CA2561819A1 Prodrugs of ion channel modulating compounds and uses thereof
12/01/2005CA2508585A1 Transdermal delivery system for treatment of cognitive disorders
11/2005
11/30/2005EP1600496A1 Method of inhibiting formation of volatile aldehydes and/or decomposition of fatty acids and use thereof
11/30/2005EP1600454A1 Anti-influenza virus compound comprising biflavonoid-sialic acid glycoside
11/30/2005EP1600180A2 Antiproliferative drug and delivery device
11/30/2005EP1600170A1 Sustained-release pharmaceutical composition for lung administration
11/30/2005EP1600162A1 Shelf-stable formulation of glucagon-like peptide-1
11/30/2005EP1600154A1 Osmotic extended-release dosage form
11/30/2005EP1600143A1 SKIN PREPARATION FOR EXTERNAL USE CHARACTERIZED BY CONTAINING SUGAR DERIVATIVE OF a,a-TREHALOSE
11/30/2005EP1600141A1 Collagenolytic active enzyme containing compositions, and their use in the dental field
11/30/2005EP1600125A2 Coiled stent for drug delivery
11/30/2005EP1599593A2 Use of a tricyclic antidepressant drug for promoting endocytosis
11/30/2005EP1599572A2 Compositions and methods for cancer immunotherapy
11/30/2005EP1599258A1 Fumed silica embolic compositions
11/30/2005EP1599230A1 Process for generating multilayered particles
11/30/2005EP1599229A2 Implantable or insertable medical devices containing miscible polymer blends for controlled delivery of a therapeutic agent
11/30/2005EP1599228A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
11/30/2005EP1599226A1 A method of diagnosis and treatment
11/30/2005EP1599222A1 Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant
11/30/2005EP1599217A2 Methods for inhibiting viral replication in vivo
11/30/2005EP1599209A2 Inhalation composition
11/30/2005EP1599188A2 POWDER FORMULATIONS OF RECOMBINANT STAPHYLOCOCCAL, ENTEROTOXIN B (<SB>R</SB>SEB) MADE BY ATMOSPHERIC SPRAY-FREEZE DRYING FOR IMPROVED VACCINATION
11/30/2005EP1599187A2 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
11/30/2005EP1599186A1 Transmucosal drug delivery system
11/30/2005EP1423093A4 Bifunctional-modified hydrogels
11/30/2005EP1409621B1 8-tetradecenal serving as an odorous or aromatic substance
11/30/2005EP1392337B1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
11/30/2005EP1353700B1 Compositions of estrogen-cyclodextrin complexes
11/30/2005EP1317483B1 Variants of allergenic proteins of the group 2 of dermatophagoides
11/30/2005EP1313511B1 Testosterone ester formulation for human use
11/30/2005EP1267831B1 New self emulsifying drug delivery system
11/30/2005EP1257299B9 Radioactive therapeutic liposomes
11/30/2005EP1227794B1 Method for encapsulating proteins or peptides in liposomes
11/30/2005EP1223985B1 Dialysis solution including polyglycol osmotic agent
11/30/2005EP1221941A4 Powder pharmaceutical formulations
11/30/2005EP1185306B1 Use of viral vectors and charged molecules for gene therapy
11/30/2005EP1178740B1 Sports drink comprising micronutrients and viable lactobacilli
11/30/2005EP1176981B1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/30/2005EP1173153B1 Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
11/30/2005EP1156787B1 Oxadiazole compounds and compositions for delivering active agents
11/30/2005EP1140010B1 Composition and method of sequestration of skin irritants.
11/30/2005EP1115428B1 Cationic dendrimeric compounds and their use as oligonucleotide/polynucleotide carriers
11/30/2005EP1089715B1 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
11/30/2005EP1079832B1 Use of vitamin pp compounds
11/30/2005CN1703619A Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
11/30/2005CN1703249A Preparation of M(CO)3-complexes by solid phase techniques via metal assisted cleavage from the solid support
11/30/2005CN1703246A Solution for ungual and peri-ungual application
11/30/2005CN1703233A Methods and compositions for preventing oxidative degradation of proteins
11/30/2005CN1703215A Stabilized pharmaceutical preparation comprising an amorphous active substance
11/30/2005CN1703209A Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics
11/30/2005CN1703206A Plaster for the treatment of dysfunctions and disorders of nail growth
11/30/2005CN1703205A Extended, controlled-release pharmaceutical compositions using charged polymers
1 ... 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 ... 1712